Commercialisation of your regenerative medicine research: lessons from spin-out successes with..
John Sinden, CSO ReNeuron,
Karen Hodgkin, Head of clinical development, Cell Medica
Paul Kemp, CSO and CEO of Intercytex.
Hear from our distingushed speakers who have 'been there' and 'done it'.
Discussion starts at 6pm and will be followed by a drinks reception and networking.
Sponsored by OBN.
The company needs to decide whether to commercialise a product (i.e. sourcing cells from a donor that can be applied universally) or a service (i.e. providing patients with their own stem cells). This choice drastically changes the business model the companies have to adapt. Notably, further organisation is required in the latter example as providing a service of this kind necessitates coordination with hospitals and healthcare professionals.
A final obstacle for translation into the clinic of regenerative medicine products is the ‘valley of death’, defined as the lack of funding between early pre-clinical to successfully completion of Phase II clinical trials. The fact that regenerative medicine is seen as an expensive and risky process with long term timescale makes the investments from the private sector even more difficult to get.
How are companies and institution bringing regenerative medicine to life?
When & Where
Oxbridge Biotech Roundtable
Oxbridge Biotechnology Roundtable is an inter-campus movement to foster the next wave of Innovation by connecting industry professionals to academicinnovators from business, law, science (and others disciplines) across Oxbridge, London, reast of the UK and beyond.
We seek to establish an inter-campus conversation about biotech, pharma and the life sciences industry and other disciplines in longer term. Our aim uis to pair young upcoming innovators to established professionals, in our quest to MOVE IDEAS FORWARD.
Since starting in Summer of 2011 we've grown to over 4,000 members across Cambridge, Oxford, London and San Diego. We engage our community via: Education, Consulting, Communication (Blog) and a platform to source bright new ideas to market.